1. Home
  2. VTAK vs NAOV Comparison

VTAK vs NAOV Comparison

Compare VTAK & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • NAOV
  • Stock Information
  • Founded
  • VTAK 2002
  • NAOV 2003
  • Country
  • VTAK United States
  • NAOV United States
  • Employees
  • VTAK N/A
  • NAOV N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • NAOV Industrial Specialties
  • Sector
  • VTAK Health Care
  • NAOV Health Care
  • Exchange
  • VTAK Nasdaq
  • NAOV Nasdaq
  • Market Cap
  • VTAK 1.4M
  • NAOV 1.5M
  • IPO Year
  • VTAK 2018
  • NAOV N/A
  • Fundamental
  • Price
  • VTAK $0.42
  • NAOV $0.71
  • Analyst Decision
  • VTAK
  • NAOV
  • Analyst Count
  • VTAK 0
  • NAOV 0
  • Target Price
  • VTAK N/A
  • NAOV N/A
  • AVG Volume (30 Days)
  • VTAK 532.2K
  • NAOV 220.0K
  • Earning Date
  • VTAK 11-13-2024
  • NAOV 11-14-2024
  • Dividend Yield
  • VTAK N/A
  • NAOV N/A
  • EPS Growth
  • VTAK N/A
  • NAOV N/A
  • EPS
  • VTAK N/A
  • NAOV N/A
  • Revenue
  • VTAK $399,000.00
  • NAOV $3,291,000.00
  • Revenue This Year
  • VTAK $637.10
  • NAOV N/A
  • Revenue Next Year
  • VTAK $177.13
  • NAOV N/A
  • P/E Ratio
  • VTAK N/A
  • NAOV N/A
  • Revenue Growth
  • VTAK 27.07
  • NAOV 227.79
  • 52 Week Low
  • VTAK $0.31
  • NAOV $0.46
  • 52 Week High
  • VTAK $8.40
  • NAOV $1.52
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 41.01
  • NAOV 60.30
  • Support Level
  • VTAK $0.40
  • NAOV $0.62
  • Resistance Level
  • VTAK $0.62
  • NAOV $0.70
  • Average True Range (ATR)
  • VTAK 0.06
  • NAOV 0.06
  • MACD
  • VTAK -0.00
  • NAOV 0.00
  • Stochastic Oscillator
  • VTAK 9.59
  • NAOV 80.53

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

Share on Social Networks: